Product Description: GSK2334470 is a highly specific and potent inhibitor of PDK1 with an IC50 of 10 nM.
Applications: Cancer-Kinase/protease
Formula: C25H34N8O
References: [1]Najafov A, et al. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Biochem J.?2011 Jan 15;433(2):357-69./[2]Qi L, et al. PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells. Cancer Cell Int.?2015 Sep 29;15:91./[3]Scortegagna M, et al. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma. Oncogene. 2014 Aug 21;33(34):4330-9.
CAS Number: 1227911-45-6
Molecular Weight: 462.59
Compound Purity: 99.78
Research Area: Cancer
Solubility: DMSO : ≥ 50 mg/mL
Target: PDK-1